NATCO PHARMA LIMITED was incorporated in Hyderabad in 1981 with an initial investment of INR 3.3 million. With this modest beginning of the operation and staff of 20 employees, NATCO today has five manufacturing facilities in India with dedicated modern research laboratories, capabilities that allow us to develop innovative medicines.

Currently, the Company NATCO consists of more than 2,500 employees and is consistently ranked among the fastest growing pharmaceutical companies in India. NATCO is well known around the world for achievements in the field of pharmaceutical research and development.

Using his 30 years of collective professional experience in the development of innovative dosage forms, and exporting finished products to the regulated markets of various countries, the company NATCO quickly took the largest player in the global pharmaceutical industry.

NATCO exports as raw materials and finished dosage forms, the quality of which meets all international standards. Today the export share is about 50% of the total revenues of the company. All products are manufactured in facilities that are approved by the regulatory health authorities of the various countries : in America (FDA), the UK (MCA), Hungary (NIP), South Africa (W. H. O. SAMMDRA), Germany (PIC), Australia (TGA), Slovakia (SI), Brazil (ANVISA), Mexico (Cofepris), Portugal (Infarmed), etc.

Currently, the company NATCO products are exported to North America, Europe, South America, Middle East and Southeast Asia.

Pemnat, Anticancer, Pemetrexed natco pharma | natco pharma ltd | natco pharma limited

Leave a Reply

Your email address will not be published. Required fields are marked *